Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiology in Press

First published online on January 25, 2008.
Experimental Physiology (2008)
DOI: 10.1113/expphysiol.2007.040139
© The Physiological Society 2008

A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
93/5/579    most recent
expphysiol.2007.040139v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guy, J. L
Right arrow Articles by Porter, K. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guy, J. L
Right arrow Articles by Porter, K. E

Received October 31, 2007
Revised December 7, 2007
Accepted after revision January 22, 2008


Heart/Cardiac Muscle [240]

Functional angiotensin converting enzyme-2 (ACE2) is expressed in human cardiac myofibroblasts

Jodie L Guy 1, Daniel W Lambert 1, Anthony J Turner 2*, Karen E Porter 1

1 University of Leeds
2 Leeds University

* To whom correspondence should be addressed. E-mail: a.j.turner{at}leeds.ac.uk.


   Abstract
The renin-angiotensin system (RAS), in particular angiotensin II, plays an important role in cardiac remodelling. ACE and ACE2 are key players in the RAS and act antagonistically to regulate the levels of angiotensin II. In this study we reveal the functional expression of ACE2 in human cardiac myofibroblasts, cells that are essential to the maintenance of normal cardiac architecture and also play a key role in myocardial remodelling. The observed reciprocal expression of ACE and ACE2 in these cells may reflect the possible opposing activity of these two enzymes. In this study we demonstrated the presence of ACE2 as an ectoenzyme and revealed that ACE2 undergoes PMA-inducible ectodomain shedding from the membrane. When cells were exposed to a number of pathophysiological stimuli, modulation of ACE2 levels was not detected. Importantly, whilst we found ACE2 to be expressed constitutively in cardiac myofibroblasts there were no detectable levels in either vascular smooth muscle cells or vascular endothelium, indicating that ACE2 expression is not ubiquitous. In paraffin sections of atrial appendage tissue we observed a distinct staining pattern for ACE2 which appeared different from that of ACE. In conclusion, this study is the first to report co-expression of ACE and ACE2 in human cardiac myofibroblasts and may therefore present a model primary system to study the comparative cell biology of ACE2 and ACE and their potentially opposing roles in myocardial remodelling.

Key Words: Angiotensin, Enzyme, Fibroblast




This article has been cited by other articles:


Home page
Exp PhysiolHome page
M. K. Raizada and J. F. R. Paton
Recent advances in the renin-angiotensin system: angiotensin-converting enzyme 2 and (pro)renin receptor
Exp Physiol, May 1, 2008; 93(5): 517 - 518.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the The Physiological Society.